JPMIA
BMY.RT

J.P. Marvel Investment Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

J.P. Marvel Investment Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60,309
Closed -$42K – 74
2020
Q4 		$42K Hold
60,309
– – 0.01% 70
2020
Q3 		$136K Hold
60,309
– – 0.04% 68
2020
Q2 		$216K Sell
60,309
-566
-0.9% -$2.04K 0.07% 65
2020
Q1 		$231K Hold
60,875
– – 0.09% 62
2019
Q4 		$183K Buy
+60,875
New +$158K 0.05% 70

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

J.P. Marvel Investment Advisors's BMY.RT Position: Q1 2021 in Review

J.P. Marvel Investment Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 60,309 shares — an estimated $42K sold.

J.P. Marvel Investment Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $231K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • J.P. Marvel Investment Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • J.P. Marvel Investment Advisors sold 60,309 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $42K.
  • J.P. Marvel Investment Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • J.P. Marvel Investment Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $231K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2021, filed 9 Sep 2021.